HQL
$16.46
TEKLA LIFE SCIENCES INVESTORS
Fund Family: TEKLA LIFE SCIENCES INVESTORS
ENDING SOONFirst 100 Only
Help Us Build Premium ETF Tools
4 quick questions • Get LIFETIME free access
Worth $2,400→ FREE
Explore sections
Top 10 Holdings
Largest positions representing 42.7% of the portfolio
42.7%
of portfolio
Loading chart...
- Regeneron Pharmaceuticals Inc7.35%
- Amgen Inc7.28%
- Gilead Sciences Inc6.61%
- Vertex Pharmaceuticals Inc4.53%
- Alnylam Pharmaceuticals Inc3.45%
- BioMarin Pharmaceutical Inc3.44%
- State Street Institutional US Government Money Market Fund2.92%
- Insmed Inc2.42%
- ARGENX SE2.41%
- BioNTech SE2.34%
| Rank | Company | Ticker | Sector | Weight (%) |
|---|---|---|---|---|
1 | Regeneron Pharmaceuticals Inc | REGN | Manufacturing | 7.35% |
2 | Amgen Inc | AMGN | Manufacturing | 7.28% |
3 | Gilead Sciences Inc | GILD | Manufacturing | 6.61% |
4 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 4.53% |
5 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 3.45% |
6 | BioMarin Pharmaceutical Inc | BMRN | Manufacturing | 3.44% |
7 | State Street Institutional US Government Money Market Fund | GVMXX | Unknown | 2.92% |
8 | Insmed Inc | IM8N | Unknown | 2.42% |
9 | ARGENX SE | ARGX | Manufacturing | 2.41% |
10 | BioNTech SE | BNTX | Manufacturing | 2.34% |
Help Us Improve ETF Tools
Share your feedback and get early access to new features
Quick 2-minute survey→ FREE